• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.

作者信息

Afshar-Oromieh Ali, Haberkorn Uwe, Hadaschik Boris, Habl Gregor, Eder Matthias, Eisenhut Michael, Schlemmer Heinz-Peter, Roethke Matthias C

机构信息

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany,

出版信息

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1629-30. doi: 10.1007/s00259-013-2489-5. Epub 2013 Jul 2.

DOI:10.1007/s00259-013-2489-5
PMID:23817686
Abstract
摘要

相似文献

1
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.使用68Ga-PSMA配体的PET/MRI用于前列腺癌检测。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1629-30. doi: 10.1007/s00259-013-2489-5. Epub 2013 Jul 2.
2
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.使用68Ga标记的PSMA配体的PET/CT和PET/MRI混合系统在复发性前列腺癌诊断中的比较：初步经验
Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.
3
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.对雷斯克等人的回复：使用[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体进行正电子发射断层扫描（PET）成像以诊断前列腺癌：人体生物分布及肿瘤病变的首次评估
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):971-2. doi: 10.1007/s00259-013-2386-y. Epub 2013 Apr 5.
4
Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.对阿夫沙尔-奥罗米耶等人的评论：使用[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体进行PET成像诊断前列腺癌：人体生物分布及肿瘤病变的首次评估
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):969-70. doi: 10.1007/s00259-013-2385-z. Epub 2013 Apr 5.
5
[(68)Ga-PSMA as a new tracer for evaluation of prostate cancer: comparison between PET-CT and PET-MRI in biochemical recurrence].[(68)Ga-PSMA作为评估前列腺癌的新型示踪剂：生化复发时PET-CT与PET-MRI的比较]
Radiologe. 2015 Feb;55(2):89-91. doi: 10.1007/s00117-014-2792-6.
6
Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.前列腺癌转移，表现为 68Ga-PSMA PET/CT 全身扫描阳性。
Clin Nucl Med. 2015 Sep;40(9):755-6. doi: 10.1097/RLU.0000000000000870.
7
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.全身整合 [Ga]PSMA-11-PET/MR 成像在复发性前列腺癌患者中的应用：与全身 PET/CT 作为参考标准的比较。
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.
8
68Ga-PSMA PET/MR-Positive, Histopathology-Proven Prostate Cancer in a Patient With Negative Multiparametric Prostate MRI.68Ga-PSMA PET/MR 阳性、组织病理学证实的前列腺癌患者，其多参数前列腺 MRI 结果为阴性。
Clin Nucl Med. 2018 Aug;43(8):e282-e284. doi: 10.1097/RLU.0000000000002143.
9
Clinical performance of Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy.Ga-PSMA-11 PET/MRI 用于检测根治性前列腺切除术后复发性前列腺癌的临床性能。
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):20-30. doi: 10.1007/s00259-017-3850-x. Epub 2017 Oct 14.
10
Detection of brain metastasis with 68Ga-labeled PSMA ligand PET/CT: a novel radiotracer for imaging of prostate carcinoma.68Ga 标记 PSMA 配体 PET/CT 检测脑转移瘤：一种用于前列腺癌成像的新型放射性示踪剂。
Clin Nucl Med. 2015 Apr;40(4):328-9. doi: 10.1097/RLU.0000000000000709.

引用本文的文献

1
Impact of Region-of-Interest Delineation on Stability and Reproducibility of Liver SNR Measurements in Ga-PSMA PET/CT.感兴趣区勾画对镓-PSMA PET/CT中肝脏信噪比测量稳定性和可重复性的影响
World J Nucl Med. 2023 May 16;22(2):124-129. doi: 10.1055/s-0043-1768446. eCollection 2023 Jun.
2
Novel Tracers and Radionuclides in PET Imaging.正电子发射断层扫描中的新型示踪剂和放射性核素
Radiol Clin North Am. 2021 Sep;59(5):887-918. doi: 10.1016/j.rcl.2021.05.012.
3
New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging.

本文引用的文献

1
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer.用于成像前列腺癌的 2 种高亲和力 PSMA 小分子的首次人体评估。
J Nucl Med. 2013 Mar;54(3):380-7. doi: 10.2967/jnumed.112.111203. Epub 2013 Jan 9.
2
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.用[68Ga]镓标记的 PSMA 配体进行 PET 成像诊断前列腺癌：在人体中的生物分布及对肿瘤病灶的初步评估。
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24.
3
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
前列腺癌聚焦治疗的新前沿：前列腺特异性膜抗原正电子发射断层扫描/磁共振成像
World J Clin Oncol. 2021 Feb 24;12(2):61-68. doi: 10.5306/wjco.v12.i2.61.
4
[Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.[镓]镓-PSMA-11在前列腺癌中的应用：综述
Am J Nucl Med Mol Imaging. 2020 Dec 15;10(6):349-374. eCollection 2020.
5
Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction.镓-68-PSMA-11 PET的散射伪影：速尿利尿可降低其严重程度并改善散射校正。
Mol Imaging. 2018 Jan-Dec;17:1536012118811741. doi: 10.1177/1536012118811741.
6
Ga-PSMA I&T PET/CT for primary staging of prostate cancer.镓-PSMA I&T PET/CT用于前列腺癌的初始分期
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):168-177. doi: 10.1007/s00259-019-04524-z. Epub 2019 Sep 16.
7
Clinical perspectives of PSMA PET/MRI for prostate cancer.前列腺特异性膜抗原（PSMA）PET/MRI在前列腺癌中的临床应用前景
Clinics (Sao Paulo). 2018 Sep 21;73(suppl 1):e586s. doi: 10.6061/clinics/2018/e586s.
8
Magnetic resonance molecular imaging for non-invasive precision cancer diagnosis.用于非侵入性精准癌症诊断的磁共振分子成像
Curr Opin Biomed Eng. 2017 Sep;3:67-73. doi: 10.1016/j.cobme.2017.11.003. Epub 2017 Nov 16.
9
Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous F-choline PET/MRI for prostate cancer.飞行时间正电子发射断层扫描对前列腺癌同步F-胆碱正电子发射断层扫描/磁共振成像中定量准确性和病灶检测的影响。
EJNMMI Res. 2018 May 31;8(1):41. doi: 10.1186/s13550-018-0390-8.
10
Whole Body MRI and oncology: recent major advances.全身磁共振成像与肿瘤学：近期的重大进展
Br J Radiol. 2018 Oct;91(1090):20170664. doi: 10.1259/bjr.20170664. Epub 2018 Mar 20.
68Ga-配合物的亲脂性和基于脲的 PSMA 抑制剂用于 PET 成像的靶向特性。
Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13.
4
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体作为诊断前列腺癌的优质正电子发射断层显像（PET）示踪剂：与18F-FECH的比较
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1085-6. doi: 10.1007/s00259-012-2069-0. Epub 2012 Feb 4.